Navigation Links
Vermillion Announces Return of Eric Fung, M.D., Ph.D.
Date:10/2/2009

ive immunoassays into a single numerical score. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. The test utilizes five well-established biomarkers --- Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta2-Microglobulin (Beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) -- and a proprietary algorithm to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned.

The OVA1 Test is an aid to further assess the likelihood that malignancy is present when the physician's independent clinical and radiological evaluation does not indicate malignancy. The test should not be used without an independent clinical/radiological evaluation and is not intended to be a screening test or to determine whether a patient should proceed to surgery. Incorrect use of the OVA1 Test carries the risk of unnecessary testing, surgery, and/or delayed diagnosis.

Quest Diagnostics, which is a long-time investor in research and development of the OVA1 technology, has exclusive rights to offer the test to the clinical reference laboratory market in the U.S. for three years.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

    Contact:

    Vermillion:
    Jill Totenberg
    The Totenberg Group
    Tel:  212 994 7363
    '/>"/>
SOURCE Vermillion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Osteotech, Inc. (Nasdaq: OSTE ), a leader ... regenerative healing, announced today that it has submitted ... and Drug Administration (FDA) to obtain marketing clearance ... to repair or replace the dura mater (the ... surgical procedures. This filing is based, in ...
(Date:12/17/2009)... Institute,s Top 10 Health Industry Issues in 2010, puts healthcare cost ... for the year ahead. , ... New York, ... Top 10 Health Industry Issues in 2010, puts ... the overarching theme for the year ahead. , , , , ...
(Date:12/17/2009)... ,and PM360 Pharma Choice Awards Programs. , ... ... communications agency Goble & Associates, Inc. (G&A) recently received recognition ... interactive work. , , ,THE RX CLUB AWARDS ,The ... the following creative work: Hospira LifeShield ad campaign, VisIV sales ...
(Date:12/16/2009)... has passed as fact among historians, journalists and politicians, ... the floor of the U.S. Congress: British forces used ... , But that claim has never been fully ... a historian at Colgate University. According to Douglas,s research, ... of Modern History , no such incident ever occurred. ...
Breaking Biology Technology:Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 2Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 5Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4
... I was reminded by an article in the Chicago Tribune ... on Oct. 9, 1940, he would have been 65 years old if ... Dec. 8, 1980. He was 40 years old. The article gave a ... sure this statement is going to provoke some comment but Im letting ...
... panel The Rise of the Blog Nation. For one-fourth of ... everyone was bloging. The other three-quarters of the room received ... big deal? , ,The big deal is becoming increasingly ... the communications arsenal of corporate America. But 18 months since ...
... aircraft in World War II were given a newly ... or Foe. It was a crude system, but it ... something at a distance. Fast forward 65 years, and ... identification: RFID - radio frequency identification. , ,Since the ...
Other Biology Technology:Midwest biotech stocks drop like a rock during the third quarter 2Midwest biotech stocks drop like a rock during the third quarter 3Blogging moves to corporate America 2Blogging moves to corporate America 3Efforts to avoid friendly fire spawned ancestor of todays RFID 2Efforts to avoid friendly fire spawned ancestor of todays RFID 3Efforts to avoid friendly fire spawned ancestor of todays RFID 4Efforts to avoid friendly fire spawned ancestor of todays RFID 5
(Date:12/16/2009)... Bacteria inhabited our planet for more than 4 billion ... us by as many eons more. That suggests they ... from Tel Aviv University bacteria expert Prof. Eshel Ben-Jacob ... and Astronomy, grounded in the study of bacteria, presents ... why most people should not automatically opt for the ...
(Date:12/16/2009)... global provider of business process outsourcing (BPO) services, was ... Top 100 IT project of 2009 for its biometric-enabled ... iQor. ,, "We are honored to be recognized among ... and CEO of iQor. "TeQ21 is completely transforming the ... smarter and with the added security biometrics provides. We ...
(Date:12/16/2009)... Calif. and PALM HARBOR, Fla., Dec. 2 ... Bulletin Board: CICI), a leading supplier of ... in the financial industry* and the recognized ... Systems Inc. ("Docubase"), a leading International Electronic ... that they have entered an agreement to ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 1Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 2Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 3Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 4Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 5Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 6Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 7Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 8Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis 4984 9GENova appoints Dr Philip Gould to Scientific Advisory Board 56991 1GENova appoints Dr Philip Gould to Scientific Advisory Board 56991 2GENova appoints Dr Philip Gould to Scientific Advisory Board 56991 3Opto electronic nose sniffs out toxic gases 9902 1Opto electronic nose sniffs out toxic gases 9902 2Opto electronic nose sniffs out toxic gases 9902 3
... ebbing due to degenerative diseases of the eye, the lowly ... In a study in rats, neural progenitor cells derived from ... vision of animals with degenerative eye disease similar to the ... today (March 28) in the journal Public Library of Science ...
... to eat prawns without the fear of an adverse ... removing from prawns the proteins that cause an allergic ... in Chemistry & Industry, the magazine of the SCI. ... University of China. The team revealed that treating prawns ...
... in which fruit flies might react to extreme fluctuations ... hardening") has been known to have negative effects on ... have advantages too. Flies exposed to heat hardening were ... on very hot days than were the flies that ...
Other Biology News:Stem cell therapy shows promise for rescuing deteriorating vision 2Stem cell therapy shows promise for rescuing deteriorating vision 3
RABBIT ANTI TRANSFERRIN RECEPTOR...
ANTI FLAG EP CL VEC...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
Biology Products: